Businessman climbing steps to pluck a star from the sky
Biotech

Merus hails 'unprecedented' survival on solid tumor bispecific

Merus reported a 79% 12-month survival rate, cementing William Blair analysts' belief the candidate has a “best-in-disease profile.”
Nick Paul Taylor May 23, 2025 7:35am
An arrow incrementally going up stairs before pointing straight up Blue background

Endometrial cancer data on Genmab’s Elahere rival beat forecast

May 23, 2025 9:22am
DNA genome CRISPR gene editing

Roche taps Broad Institute to test SBX sequencing in the clinic

May 23, 2025 10:30am
President Donald Trump arrives to speak during a rally at Macomb Community College on April 29 2025 at Warren Michigan Tru
Favicon Fierce Healthcare

Court blocks HHS RIF again after Trump's Supreme Court appeal

May 23, 2025 10:30am
Paraglider over Lake Tahoe

Weight of market pressures pushes Novo CEO out—Chutes & Ladders

May 23, 2025 8:30am
time minute

Innate says lymphoma data shows anti-KIR3DL2 antibody’s promise

May 23, 2025 5:13am
More News

Biopsies illuminate potential of Candel's prostate cancer drug

May 22, 2025 6:57pm

ASCO: Cullinan drug sees 35% ORR in pretreated NSCLC

May 22, 2025 5:00pm

PacBio expands reach in China with clinical distribution deal

May 22, 2025 12:00pm

Gilead pays partner Hookipa $10M for HBV, HIV vaccines

May 22, 2025 10:10am